This HTML5 document contains 109 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
n21http://dbpedia.org/resource/File:
foafhttp://xmlns.com/foaf/0.1/
n23https://global.dbpedia.org/id/
yagohttp://dbpedia.org/class/yago/
schemahttp://schema.org/
dbthttp://dbpedia.org/resource/Template:
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
dbpedia-svhttp://sv.dbpedia.org/resource/
n13http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
n22https://www.wsj.com/articles/
freebasehttp://rdf.freebase.com/ns/
n18http://www.grid.ac/institutes/
n10http://commons.wikimedia.org/wiki/Special:FilePath/
dbpedia-fahttp://fa.dbpedia.org/resource/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n14http://api.nytimes.com/svc/semantic/v2/concept/name/nytd_porg/
wikipedia-enhttp://en.wikipedia.org/wiki/
dbphttp://dbpedia.org/property/
dbchttp://dbpedia.org/resource/Category:
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
goldhttp://purl.org/linguistics/gold/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:List_of_chief_executive_officers
dbo:wikiPageWikiLink
dbr:Agenus
Subject Item
dbr:QS-21
dbo:wikiPageWikiLink
dbr:Agenus
Subject Item
dbr:Garo_H._Armen
dbo:wikiPageWikiLink
dbr:Agenus
Subject Item
dbr:Agenus
rdf:type
dbo:Organisation schema:Organization wikidata:Q43229 wikidata:Q4830453 n13:Agent n13:SocialPerson dbo:Agent yago:Organization108008335 dbo:Company yago:SocialGroup107950920 yago:YagoLegalActor yago:YagoLegalActorGeo yago:WikicatCompaniesListedOnNASDAQ owl:Thing yago:Institution108053576 yago:YagoPermanentlyLocatedEntity yago:WikicatBiotechnologyCompaniesOfTheUnitedStates yago:Company108058098 yago:Abstraction100002137 wikidata:Q24229398 yago:Group100031264
rdfs:label
Agenus Agenus
rdfs:comment
Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants that can be used with a range of vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients. Agenus är ett bioteknikföretag med bas i Lexington, Massachusetts, med inriktning mot immunoterapi inklusive immunonkologi.. Agenus, (tidigare Antigenics Inc.) grundades 1994 av och Pramod K. Srivastava. Företaget är listat på den amerikanska aktiebörsen, NASDAQ.
foaf:name
Agenus Inc.
dbp:name
Agenus Inc.
foaf:depiction
n10:Garo_Armen_current.jpg
dcterms:subject
dbc:Companies_listed_on_the_Nasdaq dbc:Biotechnology_companies_of_the_United_States dbc:1994_establishments_in_Massachusetts dbc:Biotechnology_companies_established_in_1994 dbc:Companies_based_in_Lexington,_Massachusetts
dbo:wikiPageID
6043137
dbo:wikiPageRevisionID
1096884528
dbo:wikiPageWikiLink
dbr:Chief_Executive_Officer dbc:Companies_listed_on_the_Nasdaq dbr:Triterpene_glycoside dbr:RTS,S dbc:Biotechnology_companies_of_the_United_States dbr:Garo_H._Armen dbr:QS21 dbc:1994_establishments_in_Massachusetts dbr:Immuno-oncology dbr:NASDAQ dbr:Defense_Production_Act_of_1950 dbr:QS-21 n21:Garo_Armen_current.jpg dbr:Ludwig_Cancer_Research dbr:Oxford–AstraZeneca_COVID-19_vaccine dbr:Novavax_COVID-19_vaccine dbr:Russell_2000_Index dbr:President_(corporate_title) dbr:Pharmaceutical_Company dbr:Chief_Operating_Officer dbc:Biotechnology_companies_established_in_1994 dbr:Biotechnology dbc:Companies_based_in_Lexington,_Massachusetts dbr:Chairman
dbo:wikiPageExternalLink
n22:SB118601609662585565%3Fmod=googlenews_wsj
owl:sameAs
wikidata:Q4692116 n14:Antigenics%20Inc%20(Delaware) n23:4LsCJ freebase:m.0fm4cq yago-res:Agenus dbpedia-fa:اجنوس dbpedia-sv:Agenus
dbp:wikiPageUsesTemplate
dbt:Infobox_company dbt:Verification dbt:Authority_control dbt:Start_date_and_age dbt:When dbt:Reflist
dbo:thumbnail
n10:Garo_Armen_current.jpg?width=300
dbp:founders
Garo H. Armen, Pramod K. Srivastava
dbp:industry
dbr:Pharmaceutical_Company dbr:Biotechnology
dbp:keyPeople
dbr:Garo_H._Armen Jennifer Buell
dbp:location
3
dbp:tradedAs
dbr:Russell_2000_Index NASDAQ:AGEN
dbp:type
Public
dbo:abstract
Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants that can be used with a range of vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients. Agenus är ett bioteknikföretag med bas i Lexington, Massachusetts, med inriktning mot immunoterapi inklusive immunonkologi.. Agenus, (tidigare Antigenics Inc.) grundades 1994 av och Pramod K. Srivastava. Företaget är listat på den amerikanska aktiebörsen, NASDAQ.
gold:hypernym
dbr:Lexington
skos:closeMatch
n18:grid.420152.0
prov:wasDerivedFrom
wikipedia-en:Agenus?oldid=1096884528&ns=0
dbo:wikiPageLength
8774
dbo:foundingYear
1994-01-01
dbo:foundedBy
dbr:Garo_H._Armen
dbo:industry
dbr:Biotechnology dbr:Pharmaceutical_Company
dbo:keyPerson
dbr:Chief_Operating_Officer dbr:Chief_Executive_Officer dbr:Garo_H._Armen dbr:President_(corporate_title) dbr:Chairman
foaf:isPrimaryTopicOf
wikipedia-en:Agenus
Subject Item
dbr:Herpes_simplex_research
dbo:wikiPageWikiLink
dbr:Agenus
Subject Item
dbr:Agenus_Inc.
dbo:wikiPageWikiLink
dbr:Agenus
dbo:wikiPageRedirects
dbr:Agenus
Subject Item
dbr:Antigenics_Inc.
dbo:wikiPageWikiLink
dbr:Agenus
dbo:wikiPageRedirects
dbr:Agenus
Subject Item
wikipedia-en:Agenus
foaf:primaryTopic
dbr:Agenus